More Nexalis Therapeutics Limited news
Nexalis Therapeutics LimitedASX: NX1

Update on Medicinal Cannabis opportunities

Apr 4, 2017 at 12:04 AM EDT · Issued by Nexalis Therapeutics Limited

Filed with ASX · Apr 4, 2017 at 12:04 AM EDT

On 6ix: 6ix.com/news/update-on-medicinal-cannabis-opportunities

Nexalis Therapeutics Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Nexalis Therapeutics Limited on 6ix

Story so far

  • Exploring opportunities in Medicinal CannabisMar 28, 2017

Earlier from Nexalis Therapeutics

  • Exploring opportunities in Medicinal CannabisMar 27, 2017
  • Lifespot Health wins major contract & strategic b2b partnerMar 7, 2017
  • Lifespot Health to enter coagulation home monitoring marketFeb 2, 2017
  • Market UpdateJan 15, 2017
  • ASX Market Release - Admission to the Official ListJan 10, 2017

Later from Nexalis Therapeutics

  • LSH enters $50Bn Global Medicinal Cannabis marketMay 1, 2017
  • Business & Operational UpdateMay 18, 2017
  • Digital Health Consortium Formed To Target $3.5B MarketJul 28, 2017
  • Lifespot Signs Global Agreement With BeurerSep 7, 2017
  • Lifespot Health restructures its Business and BoardNov 1, 2017
All Nexalis Therapeutics news releases↗

Follow Nexalis Therapeutics into a list and get an email when it puts out news.

Follow Nexalis Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer